Summary
University of Minnesota (UM) is an educational institute that offers research, education and outreach services. The institute offers educational programs in the areas of medicine, social sciences, science and business. It offers under graduate degree, post graduate, masters and research courses. UM’s schools and colleges offers courses in the areas of allied health programs, biological sciences, continuing education, dentistry, design, education and human development, extension, food, and agricultural and natural resource sciences. The institute offers graduate and professional programs in the areas of accountancy, aerospace engineering, animal sciences, applied plant sciences, biomedical engineering, chemical engineering, economics, food science, geography, and others . UM is headquartered in Minneapolis, Minnesota, the US.
University of Minnesota - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Minnesota, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Minnesota, Medical Devices Deals, 2011 to YTD 2017 9
University of Minnesota, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
University of Minnesota, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Oxis International Enters into Research Agreement with University of Minnesota 12
Oxis International Enters into Research Agreement with University of Minnesota 13
Biocept Enters into Research Agreement with University of Minnesota 14
Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 15
Targazyme Enters into Agreement with University of Minnesota Medical Center 16
Fate Therapeutics Enters into Research Agreement with Regents of the University of Minnesota 17
Licensing Agreements 18
PlasmaTech Biopharma Enters into Licensing Agreement with University of Minnesota 18
Apogen Biotech Enters into Licensing Agreement with University of Minnesota 19
Cellectis Enters Into Licensing Agreement With University Of Minnesota 20
Oxis Biotech Enters into Licensing Agreement with University of Minnesota 21
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 22
RedHill Biopharma Enters into Licensing Agreement with University of Minnesota 23
Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 24
Minneamrita Therapeutics Enters into Licensing Agreement with University of Minnesota 25
University Of Minnesota Enters Into Licensing Agreement With Vytacera Pharma 26
Ariel Pharma Enters Into Licensing Agreement With University of Minnesota For Tamiasyn 27
Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota 28
University Of Minnesota Enters Into Licensing Agreement With Flagship Biosciences 29
Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota 30
University of Minnesota - Key Competitors 31
University of Minnesota - Key Employees 32
University of Minnesota - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Recent Developments 35
Government and Public Interest 35
May 09, 2017: Delta-Opioid Agonists Can Attenuate Cardiac Injury 35
Dec 19, 2016: UMN researchers provide molecular portraits of a new cancer drug target 36
Sep 07, 2016: UNC and Minnesota researchers earn NIH grant to explore infant brain development 37
Feb 02, 2016: UMN study identifies mechanism for drug target to help block HIV's ability to spread 39
Product News 40
Oct 20, 2016: Optimal treatment plan for chronic myeloid leukemia suggested by mathematical modeling 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41
List Of Tables
List of Tables
University of Minnesota, Pharmaceuticals & Healthcare, Key Facts 2
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Minnesota, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Minnesota, Deals By Therapy Area, 2011 to YTD 2017 8
University of Minnesota, Medical Devices Deals, 2011 to YTD 2017 9
University of Minnesota, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oxis International Enters into Research Agreement with University of Minnesota 12
Oxis International Enters into Research Agreement with University of Minnesota 13
Biocept Enters into Research Agreement with University of Minnesota 14
Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 15
Targazyme Enters into Agreement with University of Minnesota Medical Center 16
Fate Therapeutics Enters into Research Agreement with Regents of the University of Minnesota 17
PlasmaTech Biopharma Enters into Licensing Agreement with University of Minnesota 18
Apogen Biotech Enters into Licensing Agreement with University of Minnesota 19
Cellectis Enters Into Licensing Agreement With University Of Minnesota 20
Oxis Biotech Enters into Licensing Agreement with University of Minnesota 21
Regenxbio Enters into Licensing Agreement with University of Pennsylvania and University of Minnesota 22
RedHill Biopharma Enters into Licensing Agreement with University of Minnesota 23
Arno Therapeutics Enters Into Licensing Agreement With University of Minnesota 24
Minneamrita Therapeutics Enters into Licensing Agreement with University of Minnesota 25
University Of Minnesota Enters Into Licensing Agreement With Vytacera Pharma 26
Ariel Pharma Enters Into Licensing Agreement With University of Minnesota For Tamiasyn 27
Horizon Discovery Enters Into Licensing Agreement With University Of Minnesota 28
University Of Minnesota Enters Into Licensing Agreement With Flagship Biosciences 29
Horizon Discovery Enters Into Licensing Agreement With The University of Minnesota 30
University of Minnesota, Key Competitors 31
University of Minnesota, Key Employees 32
University of Minnesota, Subsidiaries 33
List Of Figures
List of Figures
University of Minnesota, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Minnesota, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Minnesota, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Minnesota, Medical Devices Deals, 2011 to YTD 2017 9
